Preclinical impairment of coronary flow reserve in patients with rheumatoid arthritis

Fabiola Atzeni1, Piercarlo Sarzi-Puttini, Giuseppe De Blasio

  • 1Rheumatology Unit, L. Sacco Hospital, University of Milan, Milan, Italy. atzenifabiola@hotmail.com

Insights

Rheumatoid arthritis (RA) patients often have silent heart issues due to microcirculation problems. Coronary flow reserve (CFR) measured by echocardiography can detect early cardiac changes in RA.

Area of Science:

  • Cardiology
  • Rheumatology
  • Medical Imaging

Background:

  • Cardiovascular disease is a common complication of rheumatoid arthritis (RA), often presenting asymptomatically.
  • The underlying cause involves microcirculation abnormalities, specifically diffuse arteriolar and capillary lesions.
  • Previous research indicates impaired coronary flow reserve (CFR) in connective tissue diseases (CTD).

Purpose of the Study:

  • To review the utility of transthoracic Doppler echocardiography for assessing CFR in RA patients.
  • To highlight CFR as an early indicator of cardiac involvement in RA.
  • To explore CFR's potential for monitoring disease progression and therapeutic responses.

Main Methods:

  • Focus on transthoracic Doppler echocardiography as a noninvasive assessment tool.
  • Review of existing studies on CFR in rheumatoid arthritis and connective tissue diseases.
  • Analysis of CFR changes in relation to RA diagnosis and clinical presentation.

Main Results:

  • Coronary flow reserve (CFR) is reduced early in RA patients, even without overt heart disease.
  • Impaired microcirculation in RA directly impacts CFR.
  • Echocardiography-based CFR assessment is feasible in this population.

Conclusions:

  • Transthoracic Doppler echocardiography is a valuable noninvasive method for assessing CFR in RA.
  • Reduced CFR serves as an early marker for subclinical cardiac abnormalities in RA patients.
  • CFR assessment can aid in monitoring RA patients and evaluating novel treatment efficacy.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...